Showing results (371-380 of 420) with videos related to

Sort By:
Pageof 42
European Urology|January 31, 2012
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classificationShahrokh F Shariat, Richard Zigeuner, Michael Rink, et al.
European Urology|January 7, 2014
Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinomaDaniel J Lee, Evanguelos Xylinas, Malte Rieken, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|November 23, 2006
Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Republic of Sao Tome and PrincipeChien-Ching Hung, Chia-Kwung Fan, Kua-Eyre Su, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|November 2, 2005
Seroprevalence of Toxoplasma gondii infection among pre-schoolchildren aged 1-5 years in the Democratic Republic of Sao Tome and Principe, Western AfricaChia-Kwung Fan, Chien-Ching Hung, Kua-Eyre Su, et al.
Urologic Oncology|May 12, 2018
Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinomaNirmish Singla, Laura-Maria Krabbe, Ahmet M Aydin, et al.
The Journal of Urology|January 18, 2012
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinomaHarun Fajkovic, Eugene K Cha, Claudio Jeldres, et al.
World Journal of Urology|May 19, 2026
Patterns of adjuvant intracavitary instillation and recurrence after endoscopic management of upper tract urothelial carcinomaPhilipp Korn, Maximilian Pallauf, Jaime O Herrera-Caceres, et al.
World Journal of Urology|April 19, 2011
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomyThomas F Chromecki, Behfar Ehdaie, Giacomo Novara, et al.
European Urology Focus|February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing TherapiesDrupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.
BJU International|August 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancerJacob I Taylor, Ashish M Kamat, Michael A O'Donnell, et al.
Pageof 42